Latest Update: As of September 20, 2026, Trulicity claims are part of the federal GLP-1 multidistrict litigation (MDL 3094) in the Eastern District of Pennsylvania, which held 4,022 pending lawsuits as of September 1, 2026. A court hearing on the admissibility of expert testimony was scheduled for September 10–18, 2026, and the defendants’ summary judgment arguments on warning labels and federal preemption are also part of this stage. We haven’t found a reported ruling on those issues yet, and no bellwether trial date or settlement has been announced. Vision-loss (NAION) claims are handled separately in MDL 3163.
Last updated: September 2026
The Trulicity lawsuit is a growing wave of legal claims against Eli Lilly. Thousands of people say this diabetes drug caused severe stomach problems, including gastroparesis, that the company never properly warned about.
If you took Trulicity and ended up in the ER with stomach paralysis, bowel blockages, or other serious injuries, you’re not alone. The number of lawsuits filed has surged heading into 2026.
This article covers everything you need to know right now. You’ll find the latest case updates, estimated settlement amounts, who qualifies, filing deadlines, and how this lawsuit stacks up against similar GLP-1 drug cases.
One striking detail: FDA adverse event reports for Trulicity include thousands of gastrointestinal complaints. Yet the original drug label downplayed those risks for years.
What Is the Trulicity Lawsuit About
The Trulicity lawsuit is a collection of product liability claims against Eli Lilly. Plaintiffs argue the company sold a dangerous drug without adequate warnings about severe gastrointestinal injuries.
Trulicity, known by its generic name dulaglutide, is a GLP-1 receptor agonist. Doctors prescribe it for type 2 diabetes. It works by mimicking a hormone that regulates blood sugar and slows digestion.
That slowing of digestion is where things go wrong. For some patients, digestion doesn’t just slow down. It stops.
The core legal argument is straightforward: Eli Lilly knew or should have known that Trulicity could cause gastroparesis, stomach paralysis, and bowel obstruction. Plaintiffs claim the company failed to update its warning label quickly enough.
| Key Detail | Information |
|---|---|
| Drug Name | Trulicity (dulaglutide) |
| Manufacturer | Eli Lilly and Company |
| Drug Class | GLP-1 receptor agonist |
| Primary Use | Type 2 diabetes management |
| Main Allegation | Failure to warn about severe GI injuries |
| Legal Theory | Product liability, negligence |
These aren’t minor complaints. We’re talking about hospitalizations, surgeries, feeding tubes, and permanent digestive damage. Patients who trusted their doctor’s prescription ended up with conditions they never bargained for.
Trulicity Lawsuit Update for 2026
As of 2026, Trulicity litigation is picking up speed. New filings continue to arrive in federal courts across the country, and key procedural milestones are expected this year.
The U.S. Judicial Panel on Multidistrict Litigation (JPML) has been evaluating whether to consolidate these cases into a single MDL. If consolidation happens in 2026, it would centralize pretrial proceedings before one federal judge.
Bellwether trial selections may begin later this year. Bellwether cases are test trials that help both sides gauge how juries respond to the evidence. Their outcomes often shape settlement negotiations.
Several important developments to watch in 2026:
- MDL consolidation ruling expected in the first half of 2026
- Bellwether trial selections could start by mid-year
- Discovery phase is underway in many individual cases
- New FDA safety communications may impact the legal arguments
- Plaintiff filing numbers continue to grow month over month
The pace of this litigation resembles what happened with Ozempic lawsuits roughly a year earlier. Drug companies typically fight hard during the early stages. But once bellwether trials produce plaintiff victories, settlement talks tend to accelerate.
Trulicity Lawsuit Settlement Amounts
No global settlement has been reached in the Trulicity lawsuit as of early 2026. Individual settlements remain confidential in most cases. But legal analysts have estimated potential payout ranges based on similar pharmaceutical mass tort cases.
Settlement amounts in drug injury cases depend on several factors. The severity of your injury matters most. How long you took the drug, your medical expenses, lost wages, and the strength of your medical records all play a role.
| Injury Tier | Estimated Settlement Range | Typical Injuries |
|---|---|---|
| Tier 1 (Severe) | $300,000 to $1,000,000+ | Permanent gastroparesis, feeding tube, surgery |
| Tier 2 (Moderate) | $100,000 to $300,000 | Hospitalization, extended treatment, chronic symptoms |
| Tier 3 (Lower) | $25,000 to $100,000 | ER visits, temporary symptoms, mild gastroparesis |
These are estimates, not guarantees. Every case is different.
Think of it like car insurance claims. A fender bender pays out differently than a totaled vehicle. The same logic applies here. Someone who needed emergency surgery will likely receive far more than someone who had temporary nausea.
Past GLP-1 related cases and similar pharmaceutical lawsuits suggest that plaintiffs with strong medical documentation tend to land in the higher tiers.
Key Takeaway: The Trulicity lawsuit alleges Eli Lilly hid serious stomach injury risks, with potential individual settlements ranging from $25,000 to over $1 million depending on injury severity.
Trulicity Gastroparesis Lawsuit
Gastroparesis is the central injury driving most Trulicity lawsuits. This condition means the stomach muscles stop working properly. Food sits in the stomach far too long because the organ can’t push it through the digestive tract.
Normal stomach emptying takes about 4 hours. With gastroparesis, that process can take days. Patients experience severe nausea, vomiting, bloating, weight loss, and malnutrition.
The connection between GLP-1 drugs and gastroparesis is well documented in medical literature. GLP-1 receptor agonists slow gastric motility by design. That’s partly how they reduce appetite and control blood sugar.
But Trulicity lawsuits argue that Eli Lilly downplayed this risk. The original prescribing information mentioned “nausea” and “vomiting” as side effects. It did not clearly state that the drug could cause a chronic, potentially permanent condition like gastroparesis.
Key facts about gastroparesis claims:
- Gastroparesis can be temporary or permanent
- Severe cases require surgical placement of feeding tubes
- The condition often persists even after stopping Trulicity
- Diagnostic confirmation typically requires a gastric emptying study
- FDA adverse event reports include thousands of gastroparesis cases linked to GLP-1 drugs
Patients diagnosed with gastroparesis during or after Trulicity use represent the strongest category of plaintiffs in this litigation.
Trulicity Stomach Paralysis Lawsuit
Stomach paralysis is another way of describing severe gastroparesis. In these cases, the stomach essentially shuts down. It loses the ability to contract and move food forward.
The term “stomach paralysis” appears frequently in lawsuit filings because it captures the severity better than medical jargon. Jurors understand “your stomach stopped working” more intuitively than “delayed gastric emptying.”
Symptoms of stomach paralysis linked to Trulicity include:
- Uncontrollable vomiting lasting weeks or months
- Inability to keep food or water down
- Severe dehydration requiring IV fluids
- Dangerous weight loss (some plaintiffs lost 30+ pounds)
- Abdominal pain rated at emergency-level severity
Several plaintiffs describe a pattern. They started Trulicity for diabetes. Within weeks or months, eating became impossible. Hospital visits followed. Some needed nasogastric tubes or gastric electrical stimulators.
The frustrating part is that many of these patients had no idea their diabetes medication could cause this. Their doctors didn’t warn them because the drug label didn’t emphasize the risk adequately.
| Symptom | Frequency in Plaintiffs |
|---|---|
| Chronic vomiting | Very common |
| Severe weight loss | Common |
| Hospitalization | Common |
| Feeding tube required | Moderate |
| Surgical intervention | Less common but documented |
Stomach paralysis claims tend to result in higher settlement estimates because the injuries are so severe and so clearly linked to the drug’s mechanism of action.
Who Qualifies for the Trulicity Lawsuit
You may qualify for the Trulicity lawsuit if you took the drug and developed a serious gastrointestinal condition or other qualifying injury. The key is a direct connection between your Trulicity use and your diagnosis.
Here’s a general eligibility checklist:
- You were prescribed Trulicity (dulaglutide) by a doctor
- You took the medication for any length of time
- You developed a qualifying injury during or after use
- You can document the injury with medical records
Qualifying injuries typically include:
- Gastroparesis or stomach paralysis
- Bowel obstruction or intestinal blockage
- Pancreatitis
- Thyroid cancer (medullary thyroid carcinoma)
- Gallbladder disease
- Severe, persistent vomiting or GI distress requiring hospitalization
You don’t need to have been hospitalized to qualify, though hospitalization strengthens a claim. Even an ER visit with documented GI symptoms after starting Trulicity could be enough to get your case reviewed.
| Qualification Factor | What You Need |
|---|---|
| Prescription proof | Pharmacy records showing Trulicity dispensed |
| Medical records | Diagnosis of gastroparesis, bowel obstruction, or other injury |
| Timeline connection | Symptoms developed during or after Trulicity use |
| Injury documentation | Hospital records, imaging, lab results |
One thing to keep in mind: you don’t need to prove your case before filing. That’s what the legal process is for. You just need enough evidence to show your claim is worth investigating.
Key Takeaway: Anyone who took Trulicity and developed gastroparesis, stomach paralysis, bowel obstruction, thyroid cancer, or other serious injuries may qualify to file a claim in 2026.
How to File a Trulicity Lawsuit
Filing a Trulicity lawsuit starts with contacting a law firm that handles pharmaceutical mass tort cases. Most firms offer free case evaluations. You won’t pay anything upfront because these lawyers work on contingency, meaning they only get paid if you win.
Here’s the typical step-by-step process:
- Free consultation: A lawyer reviews your situation by phone or online form
- Case evaluation: The firm checks your medical records, prescription history, and timeline
- Retainer agreement: If you qualify, you sign an agreement with the law firm
- Filing the complaint: Your attorney files the lawsuit in the appropriate court
- Discovery phase: Both sides exchange evidence, documents, and depositions
- Settlement or trial: The case either settles or goes before a jury
What documents should you gather before calling a lawyer?
- Pharmacy records showing your Trulicity prescriptions
- Medical records documenting your diagnosis
- Hospital or ER visit records
- A list of all doctors who treated your condition
- Any imaging studies (CT scans, X-rays, gastric emptying tests)
- A personal timeline of when symptoms started
Having these ready speeds up the process significantly. Think of it like preparing your tax documents before meeting an accountant. The more organized you are, the faster things move.
Most law firms handle all court filings and negotiations. You won’t need to appear in court unless your specific case goes to trial.
Trulicity Side Effects Behind the Lawsuit
The Trulicity lawsuit focuses on side effects that go far beyond typical drug reactions. While every medication has risks, plaintiffs argue Eli Lilly failed to adequately warn about the most dangerous ones.
Common side effects listed on Trulicity’s label include nausea, diarrhea, decreased appetite, and injection site reactions. These are considered mild and expected.
But the lawsuit centers on severe side effects that weren’t prominently disclosed:
- Gastroparesis: Partial or complete stomach paralysis
- Bowel obstruction: Intestinal blockage requiring surgery
- Pancreatitis: Dangerous inflammation of the pancreas
- Gallbladder problems: Including gallstones and cholecystitis
- Thyroid tumors: Including medullary thyroid carcinoma
- Ileus: Complete halt of intestinal movement
- Severe dehydration: From uncontrollable vomiting
The FDA Adverse Event Reporting System (FAERS) database contains thousands of reports involving Trulicity and gastrointestinal complications. These reports come from patients, doctors, and pharmacists.
| Side Effect Category | Severity Level | Label Warning Adequacy (per plaintiffs) |
|---|---|---|
| Nausea, diarrhea | Mild | Adequately warned |
| Gastroparesis | Severe | Inadequately warned |
| Bowel obstruction | Severe | Inadequately warned |
| Pancreatitis | Severe | Partially warned |
| Thyroid cancer | Life-threatening | Black box warning exists but disputed |
The gap between what the label said and what patients actually experienced is the foundation of every Trulicity lawsuit. Plaintiffs don’t argue the drug shouldn’t exist. They argue patients deserved better information to make informed choices.
Is the Trulicity Lawsuit a Class Action
The Trulicity lawsuit is not a class action in the traditional sense. It is a mass tort. These two legal structures look similar from the outside, but they work very differently.
In a class action, one lawsuit represents everyone. All class members receive the same outcome, usually the same payout amount. Think of it like everyone getting an equal slice of the same pie.
A mass tort is different. Each plaintiff files their own individual case. Every person’s injury, medical history, and damages are evaluated separately. Payouts vary based on the severity of each person’s harm.
| Feature | Class Action | Mass Tort (Trulicity) |
|---|---|---|
| Case structure | One lawsuit for all | Individual lawsuits |
| Payout | Same for everyone | Different per plaintiff |
| Evidence | Shared proof | Individual medical records |
| Court process | Single trial | Bellwether trials, then settlements |
| Best for | Minor identical harms | Serious, varying injuries |
Why does this matter for you? Because in a mass tort, the worse your injury, the more you could receive. Someone with permanent gastroparesis won’t get the same payout as someone with temporary nausea. That’s actually fairer.
The cases may still be grouped together for pretrial purposes through multidistrict litigation. But each person’s claim stays individual when it comes to settlement negotiations or trial.
Key Takeaway: The Trulicity lawsuit is a mass tort, not a class action, which means each plaintiff’s payout will be based on their individual injuries and damages.
Trulicity MDL Status in 2026
As of 2026, the potential consolidation of Trulicity lawsuits into a multidistrict litigation (MDL) is one of the biggest procedural questions in this case. An MDL would group all federal Trulicity cases before a single judge for pretrial proceedings.
MDL consolidation makes the process more efficient. Instead of each case going through discovery separately in different courts, one judge oversees shared procedures like document production, expert witness testimony, and key motions.
The GLP-1 drug litigation has already seen MDL activity for related drugs. The Ozempic and Wegovy MDL was consolidated in the Eastern District of Pennsylvania. Trulicity cases could follow a similar path or potentially be folded into the existing GLP-1 MDL.
Key MDL milestones to watch in 2026:
- JPML decision on consolidation
- Assignment of an MDL judge
- Establishment of a plaintiff steering committee
- Initial case management orders
- Selection of bellwether trial cases
Bellwether trials are critically important. These are a handful of representative cases that go to trial first. Their results act like a preview for both sides.
If plaintiffs win bellwether cases with large verdicts, Eli Lilly faces enormous pressure to settle the remaining cases. If the defense wins, settlement values drop. It’s basically the litigation equivalent of a test drive before committing.
Trulicity Lawsuit Payout Per Person
Individual payouts in the Trulicity lawsuit will depend entirely on the specifics of each case. There is no fixed amount that every plaintiff will receive, and no global settlement has been announced as of 2026.
Based on comparable pharmaceutical mass torts, legal analysts project the following ranges:
| Case Strength | Estimated Payout Per Person | Characteristics |
|---|---|---|
| Strongest cases | $500,000 to $1,000,000+ | Permanent injury, surgery, feeding tube, extensive hospitalization |
| Strong cases | $200,000 to $500,000 | Long-term gastroparesis, multiple hospitalizations, significant treatment |
| Moderate cases | $75,000 to $200,000 | Documented gastroparesis or obstruction, ER visits, ongoing symptoms |
| Lower-value cases | $10,000 to $75,000 | Short-term GI issues, minimal hospitalization, limited documentation |
What makes a case “strong”? Three things matter most.
First, clear medical records showing your diagnosis. A gastric emptying study confirming gastroparesis is gold.
Second, a tight timeline connecting Trulicity use to the onset of symptoms. If you started the drug in January and went to the ER in March, that’s a clear timeline.
Third, documented damages. Medical bills, lost income, and records of ongoing treatment all increase your claim’s value.
Cases with thin documentation or injuries that could be attributed to other causes will settle for less. That’s not unfair. It’s how the legal system measures damages.
Trulicity Cancer Lawsuit Claims
Some Trulicity lawsuits include cancer claims, particularly thyroid cancer. Trulicity’s prescribing information has carried a boxed warning about thyroid C-cell tumors since its FDA approval.
The boxed warning, which is the most serious type of FDA warning, states that dulaglutide caused thyroid C-cell tumors in rodent studies. The label notes that it’s unknown whether the drug causes these tumors in humans.
Plaintiffs allege that this warning wasn’t strong enough. They argue Eli Lilly had data suggesting a real human risk but relied on the “unknown in humans” language to minimize concern.
Cancer claims in the Trulicity lawsuit typically involve:
- Medullary thyroid carcinoma (MTC): A rare but aggressive thyroid cancer
- Thyroid nodules: Abnormal growths that required biopsy or surgery
- Pancreatic cancer: Some plaintiffs link pancreatitis progression to cancer risk
| Cancer Type | Connection to Trulicity | Evidence Level |
|---|---|---|
| Medullary thyroid carcinoma | Rodent studies show tumor growth | Moderate, under investigation |
| Thyroid nodules | Reported in adverse events | Documented but causation debated |
| Pancreatic cancer | Linked through chronic pancreatitis | Emerging evidence |
Cancer claims are typically valued higher than GI injury claims because the injury is life-threatening. However, these claims are harder to prove because establishing direct causation between a drug and cancer requires significant scientific evidence.
Key Takeaway: Trulicity cancer claims center on thyroid tumors and carry potentially high settlement values, but proving direct causation remains a significant legal challenge.
Trulicity Thyroid Cancer Claims
Trulicity thyroid cancer claims specifically target the drug’s known risk of thyroid C-cell tumors. This risk has been flagged since the drug’s clinical development phase.
During preclinical testing, rats given dulaglutide developed medullary thyroid carcinoma at significantly higher rates than control groups. The FDA required Eli Lilly to include a boxed warning about this finding.
But here’s the problem plaintiffs raise. The boxed warning says the risk is “unknown” in humans. That word, “unknown,” gives patients and doctors a false sense of safety. It doesn’t mean “safe.” It means “we haven’t studied it enough.”
Plaintiffs diagnosed with MTC after taking Trulicity argue they would have chosen a different diabetes medication had the warning been clearer. This is called a “failure to warn” claim, which focuses on whether the manufacturer gave enough information for patients to make an informed decision.
What strengthens a thyroid cancer claim:
- Diagnosis of MTC or thyroid tumors after starting Trulicity
- No family history of thyroid cancer
- No other known risk factors for thyroid malignancy
- Duration of Trulicity use (longer use may strengthen the claim)
- Medical records showing clean thyroid screenings before starting the drug
MTC is relatively rare in the general population, occurring in about 3% to 5% of thyroid cancers. If a plaintiff had no predisposition and developed MTC after taking Trulicity, the circumstantial evidence becomes compelling.
Trulicity Bowel Obstruction Lawsuit
Trulicity bowel obstruction lawsuits allege the drug caused intestinal blockages that required emergency medical treatment. A bowel obstruction occurs when something blocks the small or large intestine, preventing food and liquid from passing through.
GLP-1 drugs like Trulicity slow gut motility. In severe cases, this slowing can contribute to a complete blockage. When the intestine stops moving contents forward, the results can be dangerous and even fatal if not treated promptly.
Symptoms of bowel obstruction include:
- Severe abdominal cramping and pain
- Inability to pass gas or have bowel movements
- Abdominal swelling and distension
- Nausea and forceful vomiting
- Complete loss of appetite
Many bowel obstruction plaintiffs required emergency surgery. Some needed portions of their intestine removed. Others developed secondary infections or sepsis from delayed treatment.
| Bowel Obstruction Detail | Information |
|---|---|
| Common location | Small intestine |
| Treatment | Surgery, nasogastric decompression, IV fluids |
| Average hospital stay | 5 to 14 days |
| Recurring risk | Higher in patients with prior abdominal surgery |
| Link to Trulicity | Slowed gut motility leading to blockage |
These cases are particularly strong when the plaintiff had no prior history of bowel problems. If your intestines were working fine before Trulicity and suddenly stopped after starting the drug, the connection is hard to ignore.
Eli Lilly and the Trulicity Lawsuit
Eli Lilly and Company, headquartered in Indianapolis, Indiana, manufactures Trulicity. The company has been one of the largest pharmaceutical companies in the world for over a century.
Eli Lilly brought Trulicity to market in 2014 after receiving FDA approval. The drug became a blockbuster, generating billions in annual revenue. At its peak, Trulicity was one of the top-selling diabetes drugs globally.
Plaintiffs allege that Eli Lilly prioritized profits over patient safety. The core claim is that the company had access to clinical trial data, adverse event reports, and post-market surveillance information showing serious GI risks. Instead of strengthening the warning label, they kept it vague.
Key facts about Eli Lilly’s role:
- Eli Lilly earned an estimated $7.4 billion from Trulicity sales in peak years
- The company conducted clinical trials showing GI side effects
- Post-market reports to the FDA documented gastroparesis cases
- Label updates were allegedly delayed and insufficient
- Eli Lilly faces similar scrutiny over Mounjaro (tirzepatide), another GLP-1 drug
This isn’t the first time Eli Lilly has faced major litigation. The company has previously settled lawsuits involving Zyprexa, Cymbalta, and other products. Their legal strategy typically involves aggressive defense during early litigation followed by settlement negotiations once the evidence mounts.
| Eli Lilly Fast Facts | Details |
|---|---|
| Headquarters | Indianapolis, Indiana |
| Trulicity FDA approval | 2014 |
| Peak annual Trulicity revenue | Approximately $7.4 billion |
| Other GLP-1 product | Mounjaro (tirzepatide) |
| Prior major settlements | Zyprexa ($1.42 billion, 2009) |
Key Takeaway: Eli Lilly earned billions from Trulicity while allegedly downplaying serious safety risks, and the company’s history of major litigation settlements suggests this case could follow a similar path.
Trulicity Lawsuit Deadline in 2026
Filing deadlines for Trulicity lawsuits vary by state. Every state has its own statute of limitations for personal injury and product liability claims. Missing this deadline means losing your right to sue.
Most states set the statute of limitations at 2 to 3 years from the date you discovered your injury (or should have discovered it). This is called the “discovery rule.” It doesn’t start when you took the drug. It starts when you knew, or reasonably should have known, that Trulicity caused your harm.
| State Examples | Statute of Limitations | Type |
|---|---|---|
| California | 2 years | Personal injury |
| Texas | 2 years | Personal injury |
| New York | 3 years | Personal injury |
| Florida | 2 years (recently changed) | Personal injury / negligence |
| Illinois | 2 years | Personal injury |
| Pennsylvania | 2 years | Personal injury |
Why is 2026 a critical year? Because many patients first experienced symptoms or received diagnoses in 2023 and 2024. If you live in a state with a 2-year deadline, your window could close this year.
Don’t wait. Even if you’re unsure about your exact timeline, getting a free case evaluation costs nothing. A lawyer can determine whether your deadline has passed or if you still have time.
Some states apply tolling rules that can extend your deadline. For example, if you didn’t know Trulicity caused your condition until recently, the clock may not have started until that moment. But these rules are complex and vary widely.
Trulicity vs Ozempic Lawsuit Comparison
Both Trulicity and Ozempic lawsuits involve GLP-1 receptor agonist drugs, but there are meaningful differences between the two cases. Understanding these differences helps you know where your potential claim stands.
Trulicity (dulaglutide) is made by Eli Lilly. Ozempic (semaglutide) is made by Novo Nordisk. Both drugs work similarly by mimicking the GLP-1 hormone. Both have been linked to gastroparesis and other severe GI injuries.
| Comparison Point | Trulicity | Ozempic |
|---|---|---|
| Manufacturer | Eli Lilly | Novo Nordisk |
| Generic name | Dulaglutide | Semaglutide |
| FDA approval year | 2014 | 2017 |
| Primary indication | Type 2 diabetes | Type 2 diabetes |
| Off-label weight loss use | Less common | Very common |
| MDL status | Pending/under consideration | Consolidated in E.D. Pennsylvania |
| Number of lawsuits filed | Growing rapidly | Thousands already filed |
| Key injury claims | Gastroparesis, bowel obstruction, cancer | Gastroparesis, bowel obstruction, cancer |
The Ozempic litigation is further along in the legal process. It already has an established MDL with a plaintiff steering committee. Trulicity cases may eventually join the same MDL or receive their own.
One key difference: Ozempic gained massive popularity as a weight loss drug, leading to widespread off-label use. Trulicity’s user base is more focused on diabetes patients. This affects the plaintiff pool size.
However, the legal theories are nearly identical. Both cases argue failure to warn about gastroparesis and other GI injuries. Outcomes in the Ozempic MDL will almost certainly influence Trulicity case strategies and settlement values.
Quick comparison for plaintiffs: If you took both drugs, you may have separate claims against each manufacturer. Your attorney can evaluate which claim is stronger based on your timeline and diagnosis.
Frequently Asked Questions
How much money can I get from the Trulicity lawsuit?
Most estimates place individual payouts between $25,000 and $1,000,000 or more.
Your payout depends on injury severity, medical documentation, and treatment costs.
No global settlement has been finalized as of 2026, so these are projections based on similar drug lawsuits.
What is the deadline to file a Trulicity lawsuit in 2026?
Most states have a 2 to 3 year statute of limitations for personal injury claims.
The clock usually starts from when you discovered, or should have discovered, that Trulicity caused your injury.
Contact a lawyer immediately if you think your deadline might be approaching.
Does Trulicity cause stomach paralysis?
Trulicity has been linked to gastroparesis, which is a form of stomach paralysis.
GLP-1 drugs slow gastric motility by design, and in some patients this effect becomes severe and potentially permanent.
Thousands of adverse event reports document this connection.
Is there a Trulicity class action lawsuit?
The Trulicity lawsuit is a mass tort, not a class action.
Each plaintiff files an individual claim and receives a payout based on their specific injuries.
Cases may be consolidated into a multidistrict litigation for efficiency, but payouts remain individualized.
How long will the Trulicity lawsuit take to settle?
Most pharmaceutical mass tort cases take 2 to 5 years from initial filings to settlement.
Bellwether trials expected in 2026 or 2027 could accelerate negotiations.
Settlement timing depends on trial outcomes and how quickly Eli Lilly agrees to negotiate.
What Happens Next
The Trulicity lawsuit is still in its early stages, but 2026 could be a turning point. Bellwether trials, MDL decisions, and new filings will shape the outcome for thousands of plaintiffs.
If you took Trulicity and suffered serious side effects, the time to act is now. Gather your medical records, check your state’s filing deadline, and get a free case review.
Waiting costs you nothing right now. But waiting too long could cost you your entire claim.
